OSAM
MDGL icon

O'Shaughnessy Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

O'Shaughnessy Asset Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$454K Buy
846
+154
+22% +$78.9K ﹤0.01% 1643
2026
Q1 		$362K Sell
692
-591
-46% -$282K ﹤0.01% 1692
2025
Q4 		$747K Buy
1,283
+427
+50% +$218K ﹤0.01% 1288
2025
Q3 		$393K Buy
+856
New +$319K ﹤0.01% 1611

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

O'Shaughnessy Asset Management's MDGL Position: Q2 2026 in Review

O'Shaughnessy Asset Management increased its Madrigal Pharmaceuticals (MDGL) stake by 22% in Q2 2026, buying an estimated $78.9K and bringing the position to 846 shares worth $454K. The position accounts for ﹤0.01% of the portfolio, ranked #1643.

O'Shaughnessy Asset Management first reported a position in MDGL in Q3 2025 and has held it in 4 quarters since. The position peaked at $747K in Q4 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • O'Shaughnessy Asset Management held 846 shares of Madrigal Pharmaceuticals worth $454K as of Q2 2026.
  • O'Shaughnessy Asset Management bought 154 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $78.9K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #1643 holding.
  • O'Shaughnessy Asset Management first reported a position in Madrigal Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • O'Shaughnessy Asset Management's Madrigal Pharmaceuticals position peaked at $747K in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.